Ensign Peak Advisors’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-124,807
| Closed | -$21.5M | – | 2274 |
|
|
2021
Q3 | $21.5M | Sell |
124,807
-15,141
| -11% | -$2.61M | 0.04% | 304 |
|
|
2021
Q2 | $17.6M | Buy |
139,948
+13,846
| +11% | +$1.74M | 0.04% | 335 |
|
|
2021
Q1 | $17.1M | Buy |
126,102
+27,115
| +27% | +$3.68M | 0.04% | 337 |
|
|
2020
Q4 | $12.7M | Sell |
98,987
-20,037
| -17% | -$2.56M | 0.03% | 384 |
|
|
2020
Q3 | $13.4M | Buy |
119,024
+19,245
| +19% | +$2.17M | 0.03% | 383 |
|
|
2020
Q2 | $9.51M | Buy |
99,779
+10,890
| +12% | +$1.04M | 0.03% | 440 |
|
|
2020
Q1 | $7.99M | Sell |
88,889
-8,281
| -9% | -$744K | 0.03% | 401 |
|
|
2019
Q4 | $5.15M | Buy |
+97,170
| New | +$5.15M | 0.01% | 634 |
|